Načítá se...
DIPG-13. SENSITIVITY OF DIPG CELLS TO BMI-1 MODULATOR PTC596 IS INDEPENDENT OF EZH2 ACTIVITY
Despite numerous advances in understanding the biology of poor-prognosis pediatric brain tumors, DIPG remains essentially incurable. We recently validated BMI-1 as a therapeutic target in DIPG. BMI-1 is a member of the Polycomb repressive complex 1 and is highly expressed in DIPG patient tumors and...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6012134/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.106 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|